Xap Therapeutics
Cell-based multi-modal therapies for cancer and autoimmune disease, built on a modified immune-cell delivery platform
Highlights
- New on EvolcAdded 2026-10-31
About Xap Therapeutics
Xap Therapeutics develops tailor-made cell-based therapies. Its delivery platform is built on a modified cell chassis, created through genome editing and synthetic biology, that can carry therapeutic payloads such as cytokines, antibodies and nucleic acids and is designed to activate only on recognition of chosen targets.
The company is developing multi-modal therapies for complex diseases, with stated focus areas of cancer and autoimmunity.
The company is based in Cambridge, UK, where its interdisciplinary team of scientists works. Its leadership page lists a Chief Scientific Officer, a Head of Discovery Research and a board of directors.
Product: Modular cell-based delivery platform for targeted multi-modal therapies in cancer and autoimmune disease.
Jobs at Xap Therapeutics
Leadership
- James Patterson · Co-Founder & Head of Discovery ResearchSource: company website
More biotech & pharma companies
4C Biomed
Pre-clinical immuno-oncology company finding immune targets and developing antibody drugs for cancer treatmentNew on EvolcAbingdon Analytical
UKAS-accredited stability, shelf-life and method validation testing for diagnostic and medical device developersYoung companyNew on EvolcActimed Therapeutics
Clinical-stage drug developer targeting cancer cachexia and muscle wasting with S-pindolol benzoate in Phase 2New on EvolcAds Biotec
Automated laboratory instruments, consumables and purification solutions for cytogenetic, pathology and research labsNew on EvolcAixcell
Autonomous cell culture system running routine and multi-project cell-based workflows for AI/ML data generationNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Breezy HR
- Squarespace
- jQuery